Changes in costs and effects after the implementation of disease management programs in the Netherlands: variability and determinants

Table 4 Development and implementation costs by DMP

	N	Development phase*			Implementation year 1*
		Total costs without amortization ^#	Costs per patient without amortization	Costs per patient with amortization*	Total costs without amortization ^#	Costs per patient without amortization	Costs per patient with amortization
CVR-DMP 1	300	52,136	174	35	16,426	55	90
CVR-DMP 2	207	54,417	263	53	68,415	331	381
CVR-DMP 3	700	98,754	141	28	153,215	219	234
CVR-DMP 4	300	274,783	916	183	171,026	570	605
CVR-DMP 5	550	26,807	49	10	67,604	123	142
CVR-DMP 6	450	27,923	62	12	149,990	333	356
CVR-DMP 7	125	13,324	107	21	37,968	304	387
CVR-DMP 8	250	195,007	780	156	168,385	674	715
CVR-DMP 9	1,000	26,678	27	5	81,258	81	92
COPD-DMP 1	2,508	154,504	62	12	214,239	85	90
COPD-DMP 2	1,600	93,909	59	12	49,751	31	38
COPD-DMP 3	133	49,639	373	75	55,191	415	493
COPD-DMP 4	2,400	44,586	19	4	32,599	14	18
DMII-DMP 1	2,400	5,891	2	0	28,061	12	16
DMII-DMP 2	233	162,889	699	140	387,879	1,655	1,709
DMII-DMP 3	300	50,304	168	34	61,338	204	239

ISSN: 1478-7547